Halting ErbB-2 isoforms retrograde transport to the nucleus as a new theragnostic approach for triple-negative breast cancer

por Madera, Santiago, Izzo, Franco, Chervo, María F., Dupont, Agustina, Chiauzzi, Violeta A., Bruni, Sofia, Petrillo, Ezequiel, Merin, Sharon S., De Martino, Mara, Montero, Diego, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Roldán Deamicis, Agustina, Mercogliano, María F., Proietti, Cecilia J., Schillaci, Roxana, Elizalde, Patricia V., Cordo Russo, Rosalía I.
Publicado 2022

ODP571 Blockade of ErbB-2 Nuclear Function Induces the Interferon Signaling Pathway in Breast Cancer Models Resistant to Trastuzumab

por Elizalde, Patricia V, Cordo Russo, Rosalia, Madera, Santiago, Merin, Sharon S, Chervo, María F, Ebrahimie, Esmaeil, Selth, Luke, Chiauzzi, Violeta A, Dupont, Agustina, Barchuk, Sabrina, Figurelli, Silvina, Lopez Della Vecchia, Daniel, Guzmán, Pablo, Roa, Juan C, Levit, Claudio, Lebersztein, Gabriel, Anfuso, Fabiana, Proietti, Cecilia J, Schillaci, Roxana, Hickey, Theresa E, Tilley, Wayne D, Elizalde, Patricia V
Publicado 2022

Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppression

por Bruni, Sofia, Mauro, Florencia L, Proietti, Cecilia J, Cordo-Russo, Rosalia I, Rivas, Martin A, Inurrigarro, Gloria, Dupont, Agustina, Rocha, Dario, Fernández, Elmer A, Deza, Ernesto Gil, Lopez Della Vecchia, Daniel, Barchuk, Sabrina, Figurelli, Silvina, Lasso, David, Friedrich, Adrián D, Santilli, María C, Regge, María V, Lebersztein, Gabriel, Levit, Claudio, Anfuso, Fabiana, Castiglione, Teresa, Elizalde, Patricia V, Mercogliano, Maria F, Schillaci, Roxana
Publicado 2023